Disbursements Gavi has led the effort to vaccinate more than 822 million children in the 2000–2019 period, saving more than 14 million lives in the long term. Without IFFIm funds, this would not have been possible. Breakthrough vaccines IFFIm has been instrumental in helping Gavi fund breakthrough vaccines quickly and securely. For instance, IFFIm financed more than 90% of Gavi's promised payment to UNICEF to secure initial doses of pentavalent, a single shot of which immunises against five infectious diseases: diphtheria, tetanus, pertussis, haemophilus influenzae type B (Hib) and hepatitis B. Gavi could not have made that promise, including upfront cash payments, without its ability to rely on long-term, stable funding from IFFIm. Second Footer Menu ABOUT IFFIm FUNDING IMMUNISATION IMPACT INVESTOR CENTRE NEWS AND RESOURCES Footer menu Contact Sitemap Legal Notice Gavi, the Vaccine Alliance World Bank © IFFIm 2021

Partnership Model IFFIm’s unique financing model for global health is built upon partnerships between donor countries, private investors, the World Bank, and Gavi. IFFIm receives long term, legally binding pledges from donor countries and, with the help of the World Bank, turns these pledges into Vaccine Bonds. Money raised via Vaccine Bonds provides immediate funding for Gavi’s immunisation programmes. Treasury management by the World Bank As the world’s largest global development institution, the World Bank has a successful track record as an issuer and investor in the international capital markets. With the World Bank as its Treasury Manager, IFFIm has leveraged donor pledges to raise nearly US$ 6.9 billion over the 2006 to 2020 period. Immunisation programmes through Gavi, the Vaccine Alliance IFFIm funds immunisation programmes through Gavi, the Vaccine Alliance, an international organization created in 2000 to improve access to new and underused vaccines for children in the world’s poorest countries. Augmenting existing support IFFIm has transformed Gavi’s financial landscape, nearly doubling Gavi’s funding for immunisation programmes in the initial years of IFFIm’s operations. IFFIm benefits from US$ 8 billion in donor contributions over more than 30 years from the governments of Australia, Brazil, France, Italy, the Netherlands, Norway, South Africa, Spain, Sweden and the United Kingdom. These long-term pledges support the issuance of vaccine bonds and sukuks, which have been issued in various markets and various currencies, and proved remarkably popular with institutional and individual investors who want a market-based return and an ethical investment opportunity. More on this topic Japanese investors continue to show strong interest in vaccine bonds External Resources The World Bank Second Footer Menu ABOUT IFFIm FUNDING IMMUNISATION IMPACT INVESTOR CENTRE NEWS AND RESOURCES Footer menu Contact Sitemap Legal Notice Gavi, the Vaccine Alliance World Bank © IFFIm 2021